Search research articles
Contact Us
Filters
Showing results (281-290 of 775) with videos related to
Page
of 78
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2025
Alzheimer's Imaging Consortium
Ying Xia, Matthew Dean, Vincent Dore, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
February 19, 2021
Corrigendum to "Intra-cerebral haemorrhage but not neurodegenerative disease appears over-represented in deaths of Australian cadaveric pituitary hormone recipients" [J. Clin. Neurosci. 81 (2020) 78-82]
Sultan H Alnakhli, Handan Wand, Matthew Law, et al.
ACS Chemical Neuroscience
|
August 28, 2024
Single-Molecule Fingerprinting Reveals Different Growth Mechanisms in Seed Amplification Assays for Different Polymorphs of α-Synuclein Fibrils
Derrick Lau, Yuan Tang, Vijaya Kenche, et al.
Scientific Reports
|
February 22, 2024
Exploring the association between cancer and cognitive impairment in the Australian Imaging Biomarkers and Lifestyle (AIBL) study
Liwei Ma, Yi Ling Clare Low, Yuanhao Zhuo, et al.
Biochemistry
|
July 9, 2003
In vitro characterization of the presenilin-dependent gamma-secretase complex using a novel affinity ligand
Dirk Beher, Michael Fricker, Alan Nadin, et al.
Neurology
|
July 11, 2019
Determining clinically meaningful decline in preclinical Alzheimer disease
Philip S Insel, Michael Weiner, R Scott Mackin, et al.
The Journal of Biological Chemistry
|
June 23, 2009
Paradoxical condensation of copper with elevated beta-amyloid in lipid rafts under cellular copper deficiency conditions: implications for Alzheimer disease
Ya Hui Hung, Elysia L Robb, Irene Volitakis, et al.
The Lancet. Neurology
|
August 2, 2008
Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial
Lars Lannfelt, Kaj Blennow, Henrik Zetterberg, et al.
Life (Basel, Switzerland)
|
August 13, 2020
Evaluation of GammaH2AX in Buccal Cells as a Molecular Biomarker of DNA Damage in Alzheimer's Disease in the AIBL Study of Ageing
Mohammad Sabbir Siddiqui, Maxime Francois, Stephanie Rainey-Smith, et al.
Biochemistry
|
July 24, 2002
Evidence for a copper-binding superfamily of the amyloid precursor protein
Andreas Simons, Thomas Ruppert, Carsten Schmidt, et al.
Page
of 78
Search research articles
Search
Showing results (281-290 of 775) with videos related to
Sort By:
Page
of 78
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2025
Alzheimer's Imaging Consortium
Ying Xia, Matthew Dean, Vincent Dore, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
February 19, 2021
Corrigendum to "Intra-cerebral haemorrhage but not neurodegenerative disease appears over-represented in deaths of Australian cadaveric pituitary hormone recipients" [J. Clin. Neurosci. 81 (2020) 78-82]
Sultan H Alnakhli, Handan Wand, Matthew Law, et al.
ACS Chemical Neuroscience
|
August 28, 2024
Single-Molecule Fingerprinting Reveals Different Growth Mechanisms in Seed Amplification Assays for Different Polymorphs of α-Synuclein Fibrils
Derrick Lau, Yuan Tang, Vijaya Kenche, et al.
Scientific Reports
|
February 22, 2024
Exploring the association between cancer and cognitive impairment in the Australian Imaging Biomarkers and Lifestyle (AIBL) study
Liwei Ma, Yi Ling Clare Low, Yuanhao Zhuo, et al.
Biochemistry
|
July 9, 2003
In vitro characterization of the presenilin-dependent gamma-secretase complex using a novel affinity ligand
Dirk Beher, Michael Fricker, Alan Nadin, et al.
Neurology
|
July 11, 2019
Determining clinically meaningful decline in preclinical Alzheimer disease
Philip S Insel, Michael Weiner, R Scott Mackin, et al.
The Journal of Biological Chemistry
|
June 23, 2009
Paradoxical condensation of copper with elevated beta-amyloid in lipid rafts under cellular copper deficiency conditions: implications for Alzheimer disease
Ya Hui Hung, Elysia L Robb, Irene Volitakis, et al.
The Lancet. Neurology
|
August 2, 2008
Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial
Lars Lannfelt, Kaj Blennow, Henrik Zetterberg, et al.
Life (Basel, Switzerland)
|
August 13, 2020
Evaluation of GammaH2AX in Buccal Cells as a Molecular Biomarker of DNA Damage in Alzheimer's Disease in the AIBL Study of Ageing
Mohammad Sabbir Siddiqui, Maxime Francois, Stephanie Rainey-Smith, et al.
Biochemistry
|
July 24, 2002
Evidence for a copper-binding superfamily of the amyloid precursor protein
Andreas Simons, Thomas Ruppert, Carsten Schmidt, et al.
Page
of 78